Package Label.Principal Display Panel
NDC 70771-1110-8 in bottle of 180 tablets
Mesalamine Delayed-release Tablets USP, 800 mg
Rx only
180 tablets
Mesalamine Delayed-release Tablets Usp, 800 mg (F3177974 28c9 4318 Bfde Ff1cd0bd0d8a 02)
Mesalamine Tablet, Delayed Release
FDA Label NDC 70771-1110
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Mesalamine (NDC 70771-1110). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
